Lindbrook Capital »

Miragen Therapeutics shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.3k 187 17.51
2023-12-31 $4.1k 187 21.78
2023-09-30 $4.1k 268 15.34
2023-06-30 $3.7k 156 23.79
2023-03-31 $4.0k 156 25.44
2022-06-30 $12k 1.0k 11.93